Biosimilars 2017


Director of Clinical Rheumatology
Professor of Medicine and Rheumatology
Baylor University Medical Center
Clinical Professor of Internal Medicine
The University of Texas Southwestern Medical School
Arthritis Care and Research Center
Dallas, TX

Credits: 0.5

Release Date: October 27, 2017

Target Audience:This activity has been designed to meet the educational needs of rheumatologists, physician assistants, and nurse practitioners involved in the care of patients with rheumatoid arthritis (RA).

Learning Objectives: After the completion of this activity, participants should be able to:

  • Distinguish between biosimilars and biomimics (intended copies) of biopharmaceuticals
  • Describe the regulatory pathway for approval of biosimilars in the United States
  • Identify the requirements for a biosimilar to be substituted for a bio-originator
  • Evaluate the economic issues surrounding the use of biosimilars
  • PHYSICIAN ACCREDITATION STATEMENT: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and Focus Medical Communications. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation: Purdue University College of Pharmacy designates this enduring activity for a maximum of
    0.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Purdue University Continuing Nursing Education is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This program has been approved for 0.5 contact hours.

    Disclosure Statement: All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

    All additional planning committee members, staff and reviewers of Focus Medical Communications and Purdue University College of Pharmacy have no relationships to disclose.

    Dr. Cush has served as a consultant for AbbVie Inc., Amgen, Bristol-Myers Squibb, Celgene, Genentech, Horizon, Janssen Biotech, Inc., Lilly, Novartis, Pfizer Inc., Roche and UCB Inc. He has also been a clinical investigator for AbbVie Inc., AstraZeneca, Celgene, Genentech, Janssen Biotech, Inc., Novartis, and Pfizer, Inc.